Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01478048 · COMPLETED
Trial details
- NCT number
- NCT01478048
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-30
- Primary completion
- 2014-05-30
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.